Evidence map›Paper›PMID 39315130›Full record

ArticleHeliyon2024

3D Slicer combined with neuroendoscopic surgery for the treatment of basal ganglia hemorrhage after cranioplasty: A case report and literature review.

Long Zhou, Gang Xu, Kang Liu, Huikai Zhang, Pan Lei, Minghui Lu, Ping Song, Zhiyang Li, Lun Gao, Qiuwei Hua and 2 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Long ZhouDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Gang XuDepartment of Neurosurgery, Xiantao First People's Hospital, Xiantao, Hubei, China.
Kang LiuDepartment of Neurosurgery, Yangxin County People's Hospital, Yangxin, Hubei, China.
Huikai ZhangDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Pan LeiDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Minghui LuDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Ping SongDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Zhiyang LiDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Lun GaoDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Qiuwei HuaDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Qianxue ChenDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Qiang CaiDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The minimally invasive surgery through transcranial endoscopic keyhole approach has become the main surgical method for treating cerebral hemorrhage. This method has the advantages of small trauma, short surgical time, low bleeding volume, and fast postoperative recovery. However, this method is not suitable for cases where cerebral hemorrhage occurs again after skull repair surgery. Our team used 3D Slicer reconstruction combined with virtual reality technology to find a suitable keyhole surgical approach and successfully completed a neuroendoscopic removal of basal ganglia hemorrhage through the eyebrow arch keyhole approach in a case of recurrent cerebral hemorrhage after cranioplasty.

Indexed as

3D SlicerBasal ganglia cerebral hemorrhageCranioplastySupraorbital keyhole approachTranscranial neuroendoscopy

Identifiers

PMID39315130
PMCPMC11417234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.